Diabetes and Lipid Disorders Flashcards
Where are most insulin receptors found in human body?
Liver, Muscle and Fat cells
Describe how the number of insulin receptors are controlled
In HIGH insulin concentrations, number of receptors decline, responsiveness to insulin decreases –> leads to insulin RESISTANCE
In LOW insulin concentrations, number of receptors increases, and responsiveness to insulin INCREASES
List some of the common actions of insulin.
Increases glucose uptake by cells (cells convert to glycogen or fat)
Decreases hepatic output of glucose (by decreased glycogenolysis and gluconeogenesis)
Increases amino acid and potassium uptake by cells
Inhibits Lipolysis
Enhances Protein Synthesis
Why can insulin not be taken orally?
It is digested when swallowed
Describe the two types of insulin regimens used by patients with Type 1 Diabetes Mellitus.
TWICE DAILY REGIMEN
A biphasic insulin is injected twice a day (pre-breakfast and pre-evening meal)
BASAL BOLUS REGIMEN (most common)
Intermediate or Long Acting Insulin is given at bedtime to cover overnight insulin requirements. Combined with rapid or short acting insulins to cover mealtimes
Describe the limitations of the twice daily regimen and how they might be overcome
It assumes the patients eats 3 meals a day
The peak and trough of the evening dose can lead to nocturnal hypoglycemia and then fasting hyperglycemia in the morning. Also means additional snacks often needed in the day to avoid hypoglycemia –>can be difficult to achieve optimum glyceamic control.
Giving rapid acting analogues instead of soluble insulin can help reduce incidence of hypo’s
Describe when insulin pump therapy should be considered for patients with Type 1 Diabetes
Attempts to achieve target HbA1c with MDI results in repeated and unpredictable hypoglycemic episodes which leads to persistant anxiety about hypos and reduced quality of life.
HbA1c levels remain high (8.5% or 69mmol/mol or above) despite a high level of care
In what patients should rapid acting insulin analagous be considered over traditional soluble insulins
Those who wish to inject shortly before or immediately after meals (helpful for unpredictable meals or young children)
Those prone to hypoglycemia between meals
Those prone to nocturnal hypoglycemia
Avoiding the need for snacks between meals
What basal insulin should be used in patients who use rapid acting as bolus
Long acting (rather than intermediate NPH)
Describe the ways in which hypoglycemic symptoms can be blunted in patients with diabetes
Very tight control of diabetes - lowers blood glucose concentration needed to trigger hypoglycemic symptoms
Frequent episodes of hypoglycemia - reduce the warning symptoms (esp if hypos happening overnight and patient can’t tell
Beta-blockers can also blunt hypoglycemia awareness
Some patients have reported that switching to human insulin has led to a loss of hypo warning symptoms - clinical trials do not confirm this
Briefly described insulin administration peri-operatively
NIGHT BEFORE
Give injection of patients normal insulin
MORNING OF
IV infusion of glucose and KCl at a rate dependent on patients fluid requirements (usually 125ml/hr) alongside a solution of soluble insulin in saline synringe pump piggy backed to IV infusion
Should adjust rate of insulin infusion dependent on patients blood glucose concentration - frequent monitoring necessary.
Describe how to restart patients on their normal insulin once patient starts to eat and drink
Give SC insulin before meal and stop IV infusion 30 minutes later
Describe the lifestyle interventions recommended in Type 2 Diabetes
DIET Reduce calorie load and reduce refined sugar --> Reduce Obesity --> Reduce Insulin Resistance INCREASE PHYSICAL ACTIVITY --> Increase insulin sensitivity
Describe when oral hypoglycemic drugs may be considered in Type 2 Diabetes
Only if the patients fails to respond adequately to 3 MONTHS of reduced dietary intake and increased physical activity
Drugs should be used to augment the effect of diet and exercise, not to replace them.
Describe how insulin may added to oral hypoglycemic therapy
If given alongside - intermediate or long acting insulin given at bedtime
If replaces oral hypoglycemic agents - twice daily biphasic insulin injections